Recent Visitors
Stuart D. Wilson MDStuart D. Wilson MD
Beth A. Erickson MDBeth A. Erickson MD
Christina Runge PhDChristina Runge PhD
Michael E. Widlansky MDMichael E. Widlansky MD
Herodotos Ellinas MDHerodotos Ellinas MD

Selim Firat MD Online Profile

Selim Firat MD

Associate Professor
Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical


Publications

  • Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary? (Bedi M, Firat S, Semenenko VA, Schultz C, Tripp P, Byhardt R, Wang D) Int J Radiat Oncol Biol Phys 2012 May 1;83(1):e87-92 PMID 22516389
  • Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate. (Lawton CA, Yan Y, Lee WR, Gillin M, Firat S, Baikadi M, Crook J, Kuettel M, Morton G, Sandler H) Int J Radiat Oncol Biol Phys 2012 Apr 1;82(5):e795-801 PMID 22330999
  • Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck. (Kharofa J, Choong N, Wang D, Firat S, Schultz C, Sadasiwan C, Wong S) Int J Radiat Oncol Biol Phys 2012 Jun 1;83(2):690-5 PMID 22112556
  • Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study. (Siker ML, Firat SY, Mueller W, Krouwer H, Schultz CJ) Int J Radiat Oncol Biol Phys 2012 Feb 1;82(2):765-72 PMID 21236600
  • The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2010 Dec 1;78(5):1394-9 PMID 20646856
  • Epstein-Barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent. (Gupta S, Havens PL, Southern JF, Firat SY, Jogal SS) J Pediatr Hematol Oncol 2010 May;32(4):e144-7 PMID 20224440
  • Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019. (Lee WR, Bae K, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Cancer 2007 Apr 15;109(8):1506-12 PMID 17340591
  • Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. (Li XA, Qi XS, Pitterle M, Kalakota K, Mueller K, Erickson BA, Wang D, Schultz CJ, Firat SY, Wilson JF) Int J Radiat Oncol Biol Phys 2007 Jun 1;68(2):581-91 PMID 17331669
  • A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019. (Lee WR, Bae K, Lawton CA, Gillin MT, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Brachytherapy 2006 Oct-Dec;5(4):239-43 PMID 17118317
  • Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC). (Firat S, Pleister A, Byhardt RW, Gore E) Am J Clin Oncol 2006 Jun;29(3):252-7 PMID 16755178
  • A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019. (Lee WR, DeSilvio M, Lawton C, Gillin M, Morton G, Firat S, Baikadi M, Kuettel M, Greven K, Sandler H) Int J Radiat Oncol Biol Phys 2006 Mar 1;64(3):804-9 PMID 16289906
  • High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. (Firat S, Murray K, Erickson B) Int J Radiat Oncol Biol Phys 2003 Sep 1;57(1):201-7 PMID 12909234
  • Do "elderly fit" patients have less comorbidity? (Firat S, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2003 Apr 1;55(5):1166-8 PMID 12654422
  • Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. (Firat S, Byhardt RW, Gore E) Int J Radiat Oncol Biol Phys 2002 Oct 1;54(2):357-64 PMID 12243808
  • Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. (Firat S, Bousamra M, Gore E, Byhardt RW) Int J Radiat Oncol Biol Phys 2002 Mar 15;52(4):1047-57 PMID 11958901
  • Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum. (Firat S, Erickson B) Gynecol Oncol 2001 Feb;80(2):213-20 PMID 11161862